GHK-Cu (Copper Peptide)

GHK-Cu and Matrikine Signalling

UKPWritten & reviewed by The UK Peptides Editorial Team · Research library, UK Peptides2 min readLast reviewed 2026-08-233 cited sources

The short answer

A matrikine is a peptide fragment released by breakdown of extracellular matrix proteins that then acts as a signal to cells. GHK is often described this way because its sequence occurs within collagen, but the framing is a proposal about origin and role rather than a demonstrated signalling pathway.

Key facts

Matrikine definition
Matrix-derived peptide acting as a signal
Proposed origin
Released during collagen breakdown
GHK sequence in collagen
Occurs within collagen chains
Signalling receptor
Not established
Status
Proposed framing, not settled mechanism

What a matrikine is supposed to be

The concept is elegant. Extracellular matrix proteins are not just structural. When they break down, the fragments released carry information about that breakdown, and cells respond to them. A matrikine is therefore a damage signal encoded in the structure it comes from. Several such peptides are described in the matrix biology literature.

Why GHK fits the description

The Gly-His-Lys sequence occurs within collagen. Collagen turnover would therefore be expected to liberate it, providing a route by which tissue damage generates a local increase in a peptide that promotes matrix synthesis. As a story it is coherent and self-consistent, which is a large part of why the framing became popular.

Research material referenced

GHK-Cu 100mg, third-party HPLC tested

Buy GHK-Cu · £24.99

What is missing to make it a mechanism

A signal needs a receiver. Matrikine signalling implies cells detecting the fragment and responding, which requires a receptor or a defined sensing mechanism, and none has been established for GHK. Without that, the framing describes where the peptide plausibly comes from rather than how a cell would know it had arrived.

The copper complication

If GHK's dominant activity is copper delivery, then the matrikine framing and the carrier framing are describing different things. A fragment released from collagen would initially be free GHK, acquiring copper from its surroundings. Whether the signal is the peptide, the copper it collects, or the combination is not resolved, and the two accounts are usually presented as if they were one.

How to use the term

Describing GHK as a proposed matrikine is accurate. Describing it as a matrikine that signals matrix repair overstates what has been shown, because the signalling half of that sentence has no demonstrated mechanism behind it. The distinction is small in wording and large in what it claims.

Frequently asked questions

Is GHK definitely a matrikine?
It is described as one, and its sequence does occur within collagen. Whether it functions as a signal is unresolved, because no receiving mechanism has been established.
Where would GHK come from in tissue?
The proposed route is release during collagen breakdown, which would tie its local concentration to matrix turnover.
Does the matrikine idea conflict with copper delivery?
Not necessarily, but they are different accounts. A fragment released from collagen would start out as free GHK and acquire copper from its surroundings.

Extended research context

The GHK-Cu (Copper Peptide) deep dive

Deep dive: why the copper ion matters

The GHK tripeptide (Gly-His-Lys) coordinates a Cu²⁺ ion through the imidazole nitrogen of histidine, the terminal α-amino group of glycine, and a deprotonated peptide-bond nitrogen. This near-square-planar geometry is what gives the complex its characteristic deep-blue colour and its redox-modulating chemistry. Uncomplexed GHK is a different molecule pharmacologically. Nearly every peer-reviewed study attributes activity to the copper-bound form, which is why suppliers ship the pre-complexed GHK-Cu rather than plain GHK.

GHK-Cu in the transcriptomic literature

The most-cited modern papers on GHK-Cu come from the Pickart & Margolina group and independent transcriptomic re-analyses. GHK-Cu has been reported to modulate expression of >4,000 human genes at nanomolar concentrations in Broad Institute Connectivity Map re-analyses, including genes involved in DNA repair, antioxidant defence, and ECM remodelling. This gene-signature-level activity is the reason GHK-Cu appears in so many research reviews outside of dermatology.

Analytical fingerprinting of GHK-Cu

On reverse-phase HPLC, GHK-Cu elutes as a well-defined peak; free GHK and copper-free peptide impurities are distinguishable. UV-Vis at ~520 nm confirms the copper d-d transition band. Reputable suppliers publish both HPLC (≥98% area) and mass-spec identity (~340 Da complex, 340.4 free peptide) on the batch CoA.

Research applications

  • ▸In vitro fibroblast and keratinocyte gene-expression studies
  • ▸ECM turnover assays (collagen, elastin, decorin, MMP profiling)
  • ▸Wound-healing scratch assays in cell culture models
  • ▸Antioxidant-mechanism studies (copper redox modulation)
  • ▸Formulation R&D: cosmetic and topical carrier compatibility research

Handling checklist

  • ✓Store lyophilised vial at 2–8 °C, protected from light
  • ✓Reconstitute with bacteriostatic or sterile water; expect a blue-tinted solution
  • ✓Avoid contact with reducing agents (ascorbic acid destabilises Cu²⁺)
  • ✓Aliquot reconstituted solution for freeze/thaw minimisation
  • ✓Verify blue colour and CoA HPLC ≥98% before use

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Buying GHK without copper

Fix: Confirm the CoA reads GHK-Cu (copper-bound); free GHK is a different pharmacology.

✗ Mixing with vitamin C in solution

Fix: Ascorbate reduces Cu²⁺ to Cu⁺ and destabilises the complex, keep them separate.

✗ Exposing to sunlight

Fix: Store in amber vial or foil-wrapped container at 2–8 °C.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Related questions researchers ask

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

UKP

Written and reviewed by

The UK Peptides Editorial Team · Research library, UK Peptides

The editorial team is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate. Corrections are made in place and the review date updated.

More GHK-Cu (Copper Peptide) articles

Popular across the research hub

One flagship guide from every other research category.

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.